Diamant Thaci | Emerging Research Trends | Best Researcher Award

Published on by Research Data Analysis

Prof. Dr. Diamant Thaci | Emerging Research Trends | Best Researcher Award

Universität zu Lübeck | Germany

Prof. Dr. med. Diamant Thaçi is a leading dermatologist and inflammation medicine expert whose career spans clinical practice, translational research, and academic leadership. After completing a postdoctoral fellowship and receiving a DAAD Scholarship for highly talented young scientists, he specialized in dermatology and venereology and advanced through key roles at J.W. Goethe University Frankfurt, including Senior Physician for dermatological clinical research and chronic inflammatory skin diseases. He later earned his venia legendi and held a W2 Professorship before assuming major leadership positions at the University of Lübeck, where he currently directs the Institute for Inflammation Medicine, the Excellence Center for Inflammation Medicine, and the Inflammation Board. His research focuses on atopic dermatitis, psoriasis, psoriatic arthritis, and novel immunomodulatory therapies, contributing extensively to pivotal international clinical trials. With 379 documents, 20,448 citations by 13,334 documents, and an h-index of 68, he is recognized as a Highly Cited Researcher and serves on multiple international councils and editorial boards. His awards include the Theodor Stern Foundation Prize and multiple distinctions from EADV and other societies. Overall, he is regarded as one of the most influential figures in modern inflammation and dermatology research.

Profiles : Scopus | Orcid

Featured Publications

Curman, P., Thaçi, D., & Ludwig, R. J. (2025). “Increased Cardiovascular Risk in Chronic Spontaneous Urticaria: A Large Real-World Cohort Study” in Allergy.

Lebwohl, M., Gooderham, M. J., Warren, R. B., Thaçi, D., Foley, P., Gottlieb, A. B., Torres, T., Popmihajlov, Z., Jou, Y.-M., Linaberry, M., et al. (2025). “Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis” in Clinical and Experimental Dermatology.

Olbrich, H., Kridin, K., Zirpel, H., Hernandez, G., Sadik, C. D., Gaffal, E., Thaçi, D., & Ludwig, R. J. (2025). “Glucagon-like peptide-1 receptor agonists and reduced mortality, cardiovascular and psychiatric risks in patients with psoriasis: a large-scale cohort study” in British Journal of Dermatology.

Alfarsi, S., Recke, A., Gaffal, E., Klein, J. P., Zirpel, H., Kridin, K., Thaçi, D., Olbrich, H., Bieber, K., & Ludwig, R. J. (2025). “Increased risk of psychiatric disease in patients with prurigo nodularis” in British Journal of Dermatology.

Thaçi, D., Ohtsuki, M., Maul, J.-T., Szegedi, A., Luna, P. C., Lynde, C. W., Soliman, A. M., Wang, H., Kaufmann, C., Ashley, D. G., et al. (2025). “Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months” in Dermatology and Therapy.

Modafar Ati | Machine Learning and AI Applications | Best Researcher Award

Published on by Research Data Analysis

Assoc. Prof. Dr. Modafar Ati | Machine Learning and AI Applications | Best Researcher Award

Abu Dhabi University | United Arab Emirates

Assoc. Prof. Dr. Modafar Ati is an accomplished academic and researcher in Computer Science and Information Technology with extensive experience in teaching, curriculum development, and leadership. He holds a BSc in Electrical & Communication Engineering and a PhD in Electrical & Computing Engineering from Newcastle upon Tyne, UK. Dr. Ati has over three decades of experience in both academia and industry, serving in senior roles including Associate Professor at Abu Dhabi University, Acting Dean at Sohar University, and Assistant Dean at multiple institutions in Oman. His professional expertise spans software development, systems integration, networking, ICT, project management, Service-Oriented Architecture (SOA), Artificial Intelligence, Big Data, Cybersecurity, and eHealth smart systems. He has published numerous research articles focusing on AI-driven Chronic Disease Management and smart healthcare systems and has led research groups in eGovernment and ICT. Dr. Ati has received multiple grants and awards, including the Chancellor Innovation Award, and serves on editorial boards and as a senior reviewer for international journals and conferences. His teaching portfolio covers programming, network security, project management, human-computer interaction, and mobile application development. Dr. Ati’s contributions to education, research, and innovation reflect a strong commitment to advancing technology-driven solutions in healthcare, smart cities, and digital systems.

Profile : Google Scholar

Featured Publications

Hussein, A. S., Omar, W. M., Li, X., & Ati, M. (2012). “Efficient chronic disease diagnosis prediction and recommendation system” in 2012 IEEE-EMBS Conference on Biomedical Engineering and Sciences, 209–214.

Mohamed, O., Kewalramani, M., Ati, M., & Al Hawat, W. (2021). “Application of ANN for prediction of chloride penetration resistance and concrete compressive strength” in Materialia, 17, 101123.

Mohamed, O. A., Ati, M., & Najm, O. F. (2017). “Predicting compressive strength of sustainable self-consolidating concrete using random forest” in Key Engineering Materials, 744, 141–145.

Hussein, A. S., Omar, W. M., Li, X., & Ati, M. (2012). “Accurate and reliable recommender system for chronic disease diagnosis” in Global Health, 3(2), 113–118.

Ati, M., Kabir, K., Abdullahi, H., & Ahmed, M. (2018). “Augmented reality enhanced computer aided learning for young children” in 2018 IEEE Symposium on Computer Applications & Industrial Electronics.

Nora Katabi | Salivary gland cancer | Best Researcher Award

Published on by Research Data Analysis

Dr. Nora Katabi | Salivary gland cancer | Best Researcher Award

Memorial Sloan-Kettering Cancer Center  | United States

Author Profile

Scopus

Summary

Dr. Nora Katabi is a board-certified anatomic and clinical pathologist with extensive expertise in head and neck pathology, particularly salivary gland neoplasms. She currently serves as a Tenured Member and Attending Pathologist in the Department of Pathology at Memorial Sloan Kettering Cancer Center (MSKCC) in New York. With over two decades of academic and clinical experience, Dr. Katabi has established herself as a thought leader in oncologic surgical pathology. She actively contributes to international pathology committees and serves in editorial roles for leading scientific journals. Her career reflects a strong integration of clinical practice, translational research, education, and institutional leadership, advancing precision diagnostics in head and neck cancer.

Education

Dr. Katabi earned her M.D. from Damascus University School of Medicine, Syria, in 1997. She completed multiple externships in internal medicine, cardiovascular medicine, cytogenetics, and ambulatory cardiology at institutions including Brigham and Women’s Hospital (Harvard Medical School) and Wayne State University. She completed her residency in Anatomic and Clinical Pathology and served as Chief Resident at Baylor University Medical Center in Dallas. She then completed a fellowship in Oncologic Surgical Pathology at MSKCC, further solidifying her expertise in cancer pathology.

Professional Experience

Dr. Katabi began her tenure at MSKCC in 2006 as an Instructor and Chief Fellow, progressing to Assistant, Associate, and now Tenured Member of the pathology faculty. Clinically, she has advanced from Assistant to Attending Pathologist, specializing in surgical pathology of the head and neck. From 2017 to 2023, she served as Associate Program Director for the Oncologic Surgical Pathology Fellowship, overseeing fellow education, selection, and evaluation. She is a dedicated educator, delivering didactic lectures and participating in clinical training. Her involvement in the Fellowship Committee and numerous national and international presentations further demonstrates her leadership and academic engagement.

Research Interests

Dr. Katabi’s research focuses on histopathologic and molecular characterization of salivary gland tumors, particularly in identifying genetic alterations, molecular markers, and prognostic features. She has led multiple funded studies as Principal Investigator, including work on NR4A3 abnormalities in acinic cell carcinoma and PRKD gene alterations in polymorphous adenocarcinomas. Her additional research in squamous cell carcinoma of the head and neck contributes to improved tumor classification, grading, and clinical management. Dr. Katabi’s work supports a translational approach, bridging laboratory research with patient care to enhance diagnostic precision.

Publications

 Nodal Metastasis in Low Grade Salivary Gland Carcinoma: A Retrospective Analysis of Incidence, Histologic Spectrum and Outcome
Comprehensive Clinicopathologic, Morphologic, and Molecular Evaluation and Outcomes in Polymorphous Adenocarcinoma Tumors With Applicability of a 2‑Tiered Grading System

  • Author(s): (Authors not specified in preview)

  • Journal: Modern Pathology

  • Year: 2025

Sympathetic axonogenesis promotes adenoid cystic carcinoma progression

  • Author(s): Chun‑Hao Chen, Boris Reva, Nora Katabi, Avishai Wizel, Hongbo Xu, Alan L. Ho, Luc G. T. Morris, Richard L. Bakst, Anuraag S. Parikh, Yotam Drier, Sylvie Deborde, Richard J. Wong

  • Journal: Journal of Experimental Medicine